Tag Archives: Tecfidera

A lesson in product launches from Biogen

UnknownAccording to the Wall Street Journal article on Biogen’s new MS drug “”I’m just amazed at how much patient-driven conversation is going on—almost every single patient who comes into the office knows about it (new Biogen drug) ” said Dr. Markowitz.   Dr. Markowitz said so many patients were interested in taking the drug, which is thought to be more convenient than injectable alternatives and possibly safer than competing pills.  While this is good news for Biogen and shareholders there are some lessons to be learned as Biogen stubles a bit with the launch. Continue reading